CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
62.03
0.21%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.22
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Bio-Techne Corp ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 62.16
Open* 61.94
1-Year Change* -26.45%
Day's Range* 61.87 - 62.74
52 wk Range 51.79-89.91
Average Volume (10 days) 982.29K
Average Volume (3 months) 25.10M
Market Cap 11.05B
P/E Ratio 45.85
Shares Outstanding 158.15M
Revenue 1.14B
EPS 1.52
Dividend (Yield %) 0.45806
Beta 1.24
Next Earnings Date Feb 1, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 19, 2024 62.03 0.57 0.93% 61.46 62.85 61.46
Apr 18, 2024 62.16 1.28 2.10% 60.88 62.34 59.67
Apr 17, 2024 62.63 -0.86 -1.35% 63.49 64.47 62.62
Apr 16, 2024 63.93 -1.12 -1.72% 65.05 65.05 63.46
Apr 15, 2024 65.42 -1.15 -1.73% 66.57 67.28 64.92
Apr 12, 2024 66.63 1.68 2.59% 64.95 68.38 64.95
Apr 11, 2024 68.67 0.40 0.59% 68.27 70.60 68.27
Apr 10, 2024 69.44 0.54 0.78% 68.90 70.03 68.45
Apr 9, 2024 71.16 3.23 4.75% 67.93 71.19 67.63
Apr 8, 2024 68.16 0.78 1.16% 67.38 68.78 66.22
Apr 5, 2024 66.91 -0.04 -0.06% 66.95 68.20 66.33
Apr 4, 2024 66.95 -0.95 -1.40% 67.90 68.77 66.64
Apr 3, 2024 67.72 0.43 0.64% 67.29 68.71 67.27
Apr 2, 2024 68.66 1.25 1.85% 67.41 68.77 67.16
Apr 1, 2024 69.35 -0.99 -1.41% 70.34 70.34 68.50
Mar 28, 2024 70.24 1.45 2.11% 68.79 70.70 68.78
Mar 27, 2024 69.29 1.04 1.52% 68.25 69.69 67.81
Mar 26, 2024 68.28 -0.84 -1.22% 69.12 69.25 68.13
Mar 25, 2024 69.11 -1.02 -1.45% 70.13 71.63 68.91
Mar 22, 2024 71.39 -0.80 -1.11% 72.19 72.26 70.55

Bio-Techne Corp Events

Time (UTC) Country Event
Wednesday, May 1, 2024

Time (UTC)

12:30

Country

US

Event

Q3 2024 Bio-Techne Corp Earnings Release
Q3 2024 Bio-Techne Corp Earnings Release

Forecast

-

Previous

-

Time (UTC)

13:00

Country

US

Event

Q3 2024 Bio-Techne Corp Earnings Call
Q3 2024 Bio-Techne Corp Earnings Call

Forecast

-

Previous

-
Tuesday, August 6, 2024

Time (UTC)

13:30

Country

US

Event

Q4 2024 Bio-Techne Corp Earnings Release
Q4 2024 Bio-Techne Corp Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 1136.7 1105.6 931.032 738.691 714.006
Revenue 1136.7 1105.6 931.032 738.691 714.006
Cost of Revenue, Total 366.887 349.103 298.182 255.497 240.515
Gross Profit 769.815 756.496 632.85 483.194 473.491
Total Operating Expense 788.858 809.009 693.736 581.272 583.387
Selling/General/Admin. Expenses, Total 350.496 337.62 288.92 240.882 236.867
Research & Development 92.493 87.14 70.603 65.192 62.413
Depreciation / Amortization 33.2 33.5 28.4 26.358 25.21
Unusual Expense (Income) -54.218 1.646 7.631 -6.657 18.382
Operating Income 347.844 296.59 237.296 157.419 130.619
Interest Income (Expense), Net Non-Operating -8.672 5.37 -88.176 120.619 -21.561
Other, Net -0.513 -0.574 -0.945 -1.561 -0.743
Net Income Before Taxes 338.659 301.386 148.175 276.477 112.015
Net Income After Taxes 285.442 263.099 139.585 229.296 96.072
Net Income Before Extra. Items 285.263 272.051 140.41 229.296 96.072
Net Income 285.263 272.051 140.41 229.296 96.072
Income Available to Common Excl. Extra. Items 285.193 271.93 140.324 229.072 95.967
Income Available to Common Incl. Extra. Items 285.193 271.93 140.324 229.072 95.967
Diluted Net Income 285.193 271.93 140.324 229.072 95.967
Diluted Weighted Average Shares 161.855 164.116 161.932 157.604 155.568
Diluted EPS Excluding Extraordinary Items 1.76203 1.65694 0.86656 1.45347 0.61688
Dividends per Share - Common Stock Primary Issue 0.32 0.32 0.32 0.32 0.32
Diluted Normalized EPS 1.48177 1.67418 0.92006 1.41843 0.71844
Dilution Adjustment
Gain (Loss) on Sale of Assets 3.7
Total Extraordinary Items
Total Adjustments to Net Income -0.07 -0.121 -0.086 -0.224 -0.105
Minority Interest -0.179 8.952 0.825
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 301.32 294.146 271.581 269.655 288.228
Revenue 301.32 294.146 271.581 269.655 288.228
Cost of Revenue, Total 96.622 91.984 88.221 90.06 87.878
Gross Profit 204.698 202.162 183.36 179.595 200.35
Total Operating Expense 206.795 213.935 203.69 164.438 207.655
Selling/General/Admin. Expenses, Total 86.352 100.425 100.392 96.527 96.275
Research & Development 23.419 22.713 22.459 23.903 23.148
Unusual Expense (Income) 0.402 -1.187 -7.382 -46.052 0.354
Operating Income 94.525 80.211 67.891 105.217 80.573
Interest Income (Expense), Net Non-Operating -2.667 -0.693 -1.488 -3.357 -2.717
Other, Net -3.542 0.678 0.026 1.856 1.196
Net Income Before Taxes 88.316 80.196 66.429 103.716 79.052
Net Income After Taxes 75.484 70.218 50.005 89.734 61.915
Minority Interest 0 0 0 -0.179 -0.391
Net Income Before Extra. Items 75.484 70.218 50.005 89.555 61.524
Net Income 75.484 70.218 50.005 89.555 61.524
Total Adjustments to Net Income -0.018 -0.016 -0.01 -0.026 -0.026
Income Available to Common Excl. Extra. Items 75.466 70.202 49.995 89.529 61.498
Income Available to Common Incl. Extra. Items 75.466 70.202 49.995 89.529 61.498
Diluted Net Income 75.466 70.202 49.995 89.529 61.498
Diluted Weighted Average Shares 162.116 161.615 161.75 162.172 163.588
Diluted EPS Excluding Extraordinary Items 0.46551 0.43438 0.30909 0.55206 0.37593
Dividends per Share - Common Stock Primary Issue 0.08 0.08 0.08 0.08 0.08
Diluted Normalized EPS 0.46763 0.42795 0.2752 0.30797 0.37763
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 621.482 605.556 510.606 520.92 412.607
Cash and Short Term Investments 204.31 247.029 231.554 270.893 166.033
Cash & Equivalents 180.571 172.567 199.091 146.625 100.886
Short Term Investments 23.739 74.462 32.463 124.268 65.147
Total Receivables, Net 218.468 194.548 145.385 122.534 137.466
Accounts Receivable - Trade, Net 218.468 194.548 145.385 122.534 137.466
Total Inventory 171.638 141.123 116.748 103.152 91.05
Other Current Assets, Total 27.066 22.856 16.919 24.341 18.058
Total Assets 2638.69 2294.8 2262.96 2027.59 1884.41
Property/Plant/Equipment, Total - Net 324.526 288.798 281.741 248.294 154.039
Property/Plant/Equipment, Total - Gross 558.238 500.221 471.59 418.115 306.317
Accumulated Depreciation, Total -233.712 -211.423 -189.849 -169.821 -152.278
Goodwill, Net 872.737 822.101 843.067 728.308 732.667
Intangibles, Net 534.645 531.522 615.968 516.545 579.429
Other Long Term Assets, Total 285.302 46.828 11.575 13.522 5.668
Total Current Liabilities 128.509 176.018 152.284 106.668 101.985
Accounts Payable 25.679 33.865 29.384 23.09 16.21
Accrued Expenses 62.826 91.767 78.178 49.715 55.027
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 12.5 12.5 12.5 12.5
Other Current Liabilities, Total 40.004 37.886 32.222 21.363 18.248
Total Liabilities 672.176 593.035 699.986 646.397 718.821
Total Long Term Debt 350 243.41 328.827 344.243 492.66
Long Term Debt 350 243.41 328.827 344.243 492.66
Deferred Income Tax 88.982 98.994 93.125 101.09 89.754
Other Liabilities, Total 104.685 75.372 117.487 94.396 34.422
Total Equity 1966.52 1701.77 1562.97 1381.19 1165.59
Common Stock 1.576 0.392 0.39 0.385 0.379
Additional Paid-In Capital 721.543 653.657 534.411 420.536 316.797
Retained Earnings (Accumulated Deficit) 1309.46 1122.92 1085.46 1057.47 931.934
Unrealized Gain (Loss) 0 0
Other Equity, Total -66.064 -75.2 -57.291 -97.199 -83.521
Total Liabilities & Shareholders’ Equity 2638.69 2294.8 2262.96 2027.59 1884.41
Total Common Shares Outstanding 157.642 156.64 155.822 153.812 151.736
Minority Interest 0 -0.759 8.263
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 591.477 621.482 570.996 565.183 552.031
Cash and Short Term Investments 148.663 204.31 157.197 196.756 203.075
Cash & Equivalents 148.663 180.571 127.282 164.682 165.257
Short Term Investments 0 23.739 29.915 32.074 37.818
Total Receivables, Net 204.57 218.468 216.415 184.763 174.174
Accounts Receivable - Trade, Net 204.57 218.468 216.415 184.763 174.174
Total Inventory 186.08 171.638 169.464 160.233 150.009
Other Current Assets, Total 52.164 27.066 27.92 23.431 24.773
Total Assets 2755.36 2638.69 2599.7 2363.4 2350.72
Property/Plant/Equipment, Total - Net 333.96 324.526 321.547 307.788 293.843
Property/Plant/Equipment, Total - Gross 574.938 558.238 551.975 531.131 509.785
Accumulated Depreciation, Total -240.978 -233.712 -230.428 -223.343 -215.942
Goodwill, Net 969.376 872.737 870.542 869.589 865.418
Intangibles, Net 578.971 534.645 553.257 567.647 585.534
Other Long Term Assets, Total 281.576 285.302 283.354 53.194 53.895
Total Current Liabilities 127.754 128.509 141.163 128.395 137.629
Accounts Payable 28.084 25.679 27.12 24.1 30.475
Accrued Expenses 63.026 62.826 64.882 55.887 58.462
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0 0 0
Other Current Liabilities, Total 36.644 40.004 49.161 48.408 48.692
Total Liabilities 757.614 672.176 710.01 536.295 599.567
Total Long Term Debt 440 350 370 200 264.661
Long Term Debt 440 350 370 200 264.661
Deferred Income Tax 83.134 88.982 94.607 111.381 112.92
Minority Interest 0 0 0 0 0
Other Liabilities, Total 106.726 104.685 104.24 96.519 84.357
Total Equity 1997.75 1966.52 1889.69 1827.11 1751.15
Common Stock 1.584 1.576 1.573 1.571 0.392
Additional Paid-In Capital 746.606 721.543 715.052 700.684 680.057
Retained Earnings (Accumulated Deficit) 1327.57 1309.46 1246.61 1199.98 1162.52
Other Equity, Total -78.016 -66.064 -73.551 -75.125 -91.81
Total Liabilities & Shareholders’ Equity 2755.36 2638.69 2599.7 2363.4 2350.72
Total Common Shares Outstanding 158.355 157.642 157.339 157.094 156.928
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 263.099 139.585 229.296 96.072 126.15
Cash From Operating Activities 325.272 352.164 205.217 181.619 170.367
Cash From Operating Activities 101.069 87.747 82.737 78.171 64.463
Deferred Taxes 6.816 -27.431 13.13 -13.582 -46.716
Non-Cash Items 23.805 123 -114.7 48.709 24.574
Cash Taxes Paid 30.341 20.952 41.992 36.814 35.076
Cash Interest Paid 11.027 13.576 18.615 21.497 9.844
Changes in Working Capital -69.517 29.263 -5.246 -27.751 1.896
Cash From Investing Activities -96.851 -243.516 27.095 -336.799 -38.712
Capital Expenditures -44.908 -44.301 -51.744 -25.411 -20.934
Other Investing Cash Flow Items, Total -51.943 -199.215 78.839 -311.388 -17.778
Cash From Financing Activities -242.853 -62.551 -183.802 134.384 -99.188
Financing Cash Flow Items -23.373 -19.343 -7.271 -6.297 -65.885
Total Cash Dividends Paid -50.185 -49.622 -48.902 -48.364 -47.973
Issuance (Retirement) of Stock, Net -83.795 21.914 20.871 22.545 19.17
Issuance (Retirement) of Debt, Net -85.5 -15.5 -148.5 166.5 -4.5
Foreign Exchange Effects -12.092 6.369 -2.771 -0.308 -2.089
Net Change in Cash -26.524 52.466 45.739 -21.104 30.378
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 209.958 139.739 89.734 263.099 201.184
Cash From Operating Activities 171 120.465 56.081 325.272 222.555
Cash From Operating Activities 80.315 53.344 26.641 101.069 75.203
Deferred Taxes -22.651 -6.365 -4.767 6.816 7.888
Non-Cash Items -16.916 -25.94 -32.595 23.805 14.74
Cash Taxes Paid 62.583 26.411 14.892 30.341 22.965
Cash Interest Paid 5.773 5.619 3.409 11.027 8.522
Changes in Working Capital -79.706 -40.313 -22.932 -69.517 -76.46
Cash From Investing Activities -260.893 -19.797 -19.688 -96.851 -78.281
Capital Expenditures -27.413 -15.665 -9.556 -44.908 -31.338
Other Investing Cash Flow Items, Total -233.48 -4.132 -10.132 -51.943 -46.943
Cash From Financing Activities 46.838 -104.001 -31.806 -242.853 -177.125
Financing Cash Flow Items -31.311 -20.31 -20.31 -23.373 -23.318
Total Cash Dividends Paid -37.688 -25.106 -12.545 -50.185 -37.646
Issuance (Retirement) of Stock, Net 1.837 -2.585 -7.612 -83.795 -33.786
Issuance (Retirement) of Debt, Net 114 -56 8.661 -85.5 -82.375
Foreign Exchange Effects -2.23 -4.552 -11.897 -12.092 -5.419
Net Change in Cash -45.285 -7.885 -7.31 -26.524 -38.27

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Bio-Techne Corp Company profile

Bio-Techne Corporation
Industry: Biotechnology & Medical Research (NEC)

614 Mckinley Pl N E
MINNEAPOLIS
MINNESOTA 55413
US

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

XRP/USD

0.52 Price
+1.590% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,068.55 Price
-0.430% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

US100

17,037.80 Price
-1.980% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

64,233.50 Price
+0.190% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading